This is big news:

"Word came this morning that Biogen is dropping their anti-amyloid antibody (Aduhelm, aducanumab), so it's time to take stock. I was never happy about the FDA's decision to approve it, and that's putting it lightly."

https://www.science.org/content/blog-post/goodbye-aduhelm